Zenas BioPharma annual operating margin
2023
2024
2025
Zenas BioPharma Operating Margin Growth & History (ZBIO)
Zenas BioPharma's operating margin was −3,830.57% for fiscal 2025.
View full Zenas BioPharma company overviewZenas BioPharma annual operating margin history
| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −3,830.57% | −552.81 pp |
| 2024 | 2024-12-31 | −3,277.76% | −3203.47 pp |
| 2023 | 2023-12-31 | −74.29% | — |
Zenas BioPharma quarterly operating margin
Q3.23
Q1.25
Q2.26
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −10,765.90% | — |
| Q1 2025 | 2025-03-31 | −373.30% | — |
| Q3 2023 | 2023-09-30 | 71.25% | — |
Zenas BioPharma operating margin trends
Between the periods ended 2023-12-31 and 2025-12-31, Zenas BioPharma's operating margin decreased from −74.29% to −3,830.57%, a change of −3756.28 percentage points. The latest reported quarter, Q2 2026, shows −10,765.90%.
About the metric
What operating margin means
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
Calculation and source
How operating margin is calculated
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Zenas BioPharma source filings ↗